APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latanoprost

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Selected research

Market Outlook & Growth Opportunities

Global Latanoprost Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchLatanoprost Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Latanoprost Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Latanoprost Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latanoprost Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Latanoprost Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Read the full market overview

Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.

This report provides an overview of the global Latanoprost market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Latanoprost and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Latanoprost sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Latanoprost market size, projected growth trends, production technologies, key applications, and end-use industries.

Latanoprost Segment by Company

Pfizer

Mylan

Novartis

Apotex

Teva

Taj Pharma

CR Zizhu

Latanoprost Segment by Type

Brand Drug

Generic Drug

Latanoprost Segment by Application

Open-angle Glaucoma

Close-angle Glaucoma

Latanoprost Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Latanoprost status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Latanoprost market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Latanoprost significant trends, drivers, influence factors in global and regions.

6. To analyze Latanoprost competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latanoprost and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Latanoprost market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Latanoprost industry.

Chapter 3: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Latanoprost in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Latanoprost Industry Trends Table 2. Latanoprost Industry Drivers Table 3. Latanoprost Industry Opportunities and Challenges Table 4. Latanoprost Industry Restraints Table 5. Global Latanoprost Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Latanoprost Revenue Share by Company (2021-2026) Table 7. Global Latanoprost Sales Volume by Company (M Unit) & (2021-2026) Table 8. Global Latanoprost Sales Volume Share by Company (2021-2026) Table 9. Global Latanoprost Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Latanoprost Company Ranking, (2024-2026) & (USD Million) Table 11. Global Latanoprost Key Company Manufacturing Base & Headquarters Table 12. Global Latanoprost Company, Product Type & Application Table 13. Global Latanoprost Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Latanoprost by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Brand Drug Table 18. Significant Companies of Generic Drug Table 19. Global Latanoprost Sales Volume by Type 2021 VS 2025 VS 2032 (M Unit) Table 20. Global Latanoprost Sales Volume by Type (2021-2026) & (M Unit) Table 21. Global Latanoprost Sales Volume by Type (2027-2032) & (M Unit) Table 22. Global Latanoprost Sales Volume Share by Type (2021-2026) Table 23. Global Latanoprost Sales Volume Share by Type (2027-2032) Table 24. Global Latanoprost Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Latanoprost Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Latanoprost Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Latanoprost Sales Value Share by Type (2021-2026) Table 28. Global Latanoprost Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Open-angle Glaucoma Table 30. Significant Companies of Close-angle Glaucoma Table 31. Global Latanoprost Sales Volume by Application 2021 VS 2025 VS 2032 (M Unit) Table 32. Global Latanoprost Sales Volume by Application (2021-2026) & (M Unit) Table 33. Global Latanoprost Sales Volume by Application (2027-2032) & (M Unit) Table 34. Global Latanoprost Sales Volume Share by Application (2021-2026) Table 35. Global Latanoprost Sales Volume Share by Application (2027-2032) Table 36. Global Latanoprost Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Latanoprost Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Latanoprost Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Latanoprost Sales Value Share by Application (2021-2026) Table 40. Global Latanoprost Sales Value Share by Application (2027-2032) Table 41. Global Latanoprost Sales by Region: 2021 VS 2025 VS 2032 (M Unit) Table 42. Global Latanoprost Sales by Region (2021-2026) & (M Unit) Table 43. Global Latanoprost Sales Market Share by Region (2021-2026) Table 44. Global Latanoprost Sales by Region (2027-2032) & (M Unit) Table 45. Global Latanoprost Sales Market Share by Region (2027-2032) Table 46. Global Latanoprost Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Latanoprost Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Latanoprost Sales Value Share by Region (2021-2026) Table 49. Global Latanoprost Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Latanoprost Sales Value Share by Region (2027-2032) Table 51. Global Latanoprost Market Average Price (USD/Unit) by Region (2021-2026) Table 52. Global Latanoprost Market Average Price (USD/Unit) by Region (2027-2032) Table 53. Global Latanoprost Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Table 54. Global Latanoprost Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Latanoprost Sales by Country (2021-2026) & (M Unit) Table 56. Global Latanoprost Sales Market Share by Country (2021-2026) Table 57. Global Latanoprost Sales by Country (2027-2032) & (M Unit) Table 58. Global Latanoprost Sales Market Share by Country (2027-2032) Table 59. Global Latanoprost Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Latanoprost Sales Value Market Share by Country (2021-2026) Table 61. Global Latanoprost Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Latanoprost Sales Value Market Share by Country (2027-2032) Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 66. Pfizer Latanoprost Product Portfolio Table 67. Pfizer Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Mylan Latanoprost Product Portfolio Table 72. Mylan Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Novartis Latanoprost Product Portfolio Table 77. Novartis Recent Development Table 78. Apotex Company Information Table 79. Apotex Business Overview Table 80. Apotex Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Apotex Latanoprost Product Portfolio Table 82. Apotex Recent Development Table 83. Teva Company Information Table 84. Teva Business Overview Table 85. Teva Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. Teva Latanoprost Product Portfolio Table 87. Teva Recent Development Table 88. Taj Pharma Company Information Table 89. Taj Pharma Business Overview Table 90. Taj Pharma Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Taj Pharma Latanoprost Product Portfolio Table 92. Taj Pharma Recent Development Table 93. CR Zizhu Company Information Table 94. CR Zizhu Business Overview Table 95. CR Zizhu Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. CR Zizhu Latanoprost Product Portfolio Table 97. CR Zizhu Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Latanoprost Distributors List Table 101. Latanoprost Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Latanoprost Product Image Figure 2. Global Latanoprost Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latanoprost Sales Value (2021-2032) & (US$ Million) Figure 4. Global Latanoprost Sales (2021-2032) & (M Unit) Figure 5. Global Latanoprost Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Latanoprost Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brand Drug Image Figure 10. Generic Drug Image Figure 11. Global Latanoprost Sales Volume by Type (2021 VS 2025 VS 2032) & (M Unit) Figure 12. Global Latanoprost Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Latanoprost Sales Volume Share by Type (2021-2032) Figure 14. Global Latanoprost Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Latanoprost Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Latanoprost Sales Value Share by Type (2021-2032) Figure 17. Open-angle Glaucoma Image Figure 18. Close-angle Glaucoma Image Figure 19. Global Latanoprost Sales Volume by Application (2021 VS 2025 VS 2032) & (M Unit) Figure 20. Global Latanoprost Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Latanoprost Sales Volume Share by Application (2021-2032) Figure 22. Global Latanoprost Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Latanoprost Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Latanoprost Sales Value Share by Application (2021-2032) Figure 25. Global Latanoprost Sales by Region: 2021 VS 2025 VS 2032 (M Unit) Figure 26. Global Latanoprost Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Latanoprost Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Latanoprost Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Latanoprost Sales Value (2021-2032) & (US$ Million) Figure 30. North America Latanoprost Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Latanoprost Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Latanoprost Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Latanoprost Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Latanoprost Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Latanoprost Sales Value (2021-2032) & (US$ Million) Figure 36. South America Latanoprost Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Latanoprost Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Latanoprost Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Latanoprost Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Latanoprost Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Latanoprost Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Latanoprost Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Latanoprost Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Open-angle Glaucoma
  • Close-angle Glaucoma
Companies covered
  • Pfizer
  • Mylan
  • Novartis
  • Apotex
  • Teva
  • Taj Pharma
  • CR Zizhu

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Latanoprost Sales Value (2021-2032)
  4. 1.2.2 Global Latanoprost Sales Volume (2021-2032)
  5. 1.2.3 Global Latanoprost Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Latanoprost Market Dynamics
  1. 2.1 Latanoprost Industry Trends
  2. 2.2 Latanoprost Industry Drivers
  3. 2.3 Latanoprost Industry Opportunities and Challenges
  4. 2.4 Latanoprost Industry Restraints
3 Latanoprost Market by Company
  1. 3.1 Global Latanoprost Company Revenue Ranking in 2025
  2. 3.2 Global Latanoprost Revenue by Company (2021-2026)
  3. 3.3 Global Latanoprost Sales Volume by Company (2021-2026)
  4. 3.4 Global Latanoprost Average Price by Company (2021-2026)
  5. 3.5 Global Latanoprost Company Ranking (2024-2026)
  6. 3.6 Global Latanoprost Company Manufacturing Base and Headquarters
  7. 3.7 Global Latanoprost Company Product Type and Application
  8. 3.8 Global Latanoprost Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Latanoprost Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Latanoprost Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Latanoprost Market by Type
  1. 4.1 Latanoprost Type Introduction
  2. 4.1.1 Brand Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Latanoprost Sales Volume by Type
  5. 4.2.1 Global Latanoprost Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Latanoprost Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Latanoprost Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Latanoprost Sales Value by Type
  9. 4.3.1 Global Latanoprost Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Latanoprost Sales Value by Type (2021-2032)
  11. 4.3.3 Global Latanoprost Sales Value Share by Type (2021-2032)
5 Latanoprost Market by Application
  1. 5.1 Latanoprost Application Introduction
  2. 5.1.1 Open-angle Glaucoma
  3. 5.1.2 Close-angle Glaucoma
  4. 5.2 Global Latanoprost Sales Volume by Application
  5. 5.2.1 Global Latanoprost Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Latanoprost Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Latanoprost Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Latanoprost Sales Value by Application
  9. 5.3.1 Global Latanoprost Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Latanoprost Sales Value by Application (2021-2032)
  11. 5.3.3 Global Latanoprost Sales Value Share by Application (2021-2032)
6 Latanoprost Regional Sales and Value Analysis
  1. 6.1 Global Latanoprost Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Latanoprost Sales by Region (2021-2032)
  3. 6.2.1 Global Latanoprost Sales by Region: 2021-2026
  4. 6.2.2 Global Latanoprost Sales by Region (2027-2032)
  5. 6.3 Global Latanoprost Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Latanoprost Sales Value by Region (2021-2032)
  7. 6.4.1 Global Latanoprost Sales Value by Region: 2021-2026
  8. 6.4.2 Global Latanoprost Sales Value by Region (2027-2032)
  9. 6.5 Global Latanoprost Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Latanoprost Sales Value (2021-2032)
  12. 6.6.2 North America Latanoprost Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Latanoprost Sales Value (2021-2032)
  15. 6.7.2 Europe Latanoprost Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Latanoprost Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Latanoprost Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Latanoprost Sales Value (2021-2032)
  21. 6.9.2 South America Latanoprost Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Latanoprost Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Latanoprost Sales Value Share by Country, 2025 VS 2032
7 Latanoprost Country-level Sales and Value Analysis
  1. 7.1 Global Latanoprost Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Latanoprost Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Latanoprost Sales by Country (2021-2032)
  4. 7.3.1 Global Latanoprost Sales by Country (2021-2026)
  5. 7.3.2 Global Latanoprost Sales by Country (2027-2032)
  6. 7.4 Global Latanoprost Sales Value by Country (2021-2032)
  7. 7.4.1 Global Latanoprost Sales Value by Country (2021-2026)
  8. 7.4.2 Global Latanoprost Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Latanoprost Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Latanoprost Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Latanoprost Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Latanoprost Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Latanoprost Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Latanoprost Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Latanoprost Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Latanoprost Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Latanoprost Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Latanoprost Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Latanoprost Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Latanoprost Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Latanoprost Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Latanoprost Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Latanoprost Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Latanoprost Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Latanoprost Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Latanoprost Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Latanoprost Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Latanoprost Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Latanoprost Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Latanoprost Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Latanoprost Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Latanoprost Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Latanoprost Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Latanoprost Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Latanoprost Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Latanoprost Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Latanoprost Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Latanoprost Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Latanoprost Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Latanoprost Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Latanoprost Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Latanoprost Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Latanoprost Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Latanoprost Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Latanoprost Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Latanoprost Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Latanoprost Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Latanoprost Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Latanoprost Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Latanoprost Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Latanoprost Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Latanoprost Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Latanoprost Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Latanoprost Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Latanoprost Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Latanoprost Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Latanoprost Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Latanoprost Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Latanoprost Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Latanoprost Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Latanoprost Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Latanoprost Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Latanoprost Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Latanoprost Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Latanoprost Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Latanoprost Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Latanoprost Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Latanoprost Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Latanoprost Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Latanoprost Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Latanoprost Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Latanoprost Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Latanoprost Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Latanoprost Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Latanoprost Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Latanoprost Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Latanoprost Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Latanoprost Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Latanoprost Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Latanoprost Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Latanoprost Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Latanoprost Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Latanoprost Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Latanoprost Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Latanoprost Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Latanoprost Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Latanoprost Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Latanoprost Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Latanoprost Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Latanoprost Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Latanoprost Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Latanoprost Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Latanoprost Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Latanoprost Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Latanoprost Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Latanoprost Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Latanoprost Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Latanoprost Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Apotex
  20. 8.4.1 Apotex Company Information
  21. 8.4.2 Apotex Business Overview
  22. 8.4.3 Apotex Latanoprost Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Apotex Latanoprost Product Portfolio
  24. 8.4.5 Apotex Recent Developments
  25. 8.5 Teva
  26. 8.5.1 Teva Company Information
  27. 8.5.2 Teva Business Overview
  28. 8.5.3 Teva Latanoprost Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Teva Latanoprost Product Portfolio
  30. 8.5.5 Teva Recent Developments
  31. 8.6 Taj Pharma
  32. 8.6.1 Taj Pharma Company Information
  33. 8.6.2 Taj Pharma Business Overview
  34. 8.6.3 Taj Pharma Latanoprost Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharma Latanoprost Product Portfolio
  36. 8.6.5 Taj Pharma Recent Developments
  37. 8.7 CR Zizhu
  38. 8.7.1 CR Zizhu Company Information
  39. 8.7.2 CR Zizhu Business Overview
  40. 8.7.3 CR Zizhu Latanoprost Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 CR Zizhu Latanoprost Product Portfolio
  42. 8.7.5 CR Zizhu Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Latanoprost Value Chain Analysis
  2. 9.1.1 Latanoprost Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Latanoprost Sales Mode & Process
  6. 9.2 Latanoprost Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Latanoprost Distributors
  9. 9.2.3 Latanoprost Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst